/PRNewswire/ The Weight Management Devices Market report has been added to Technavio s offering. With ISO 9001:2015 certification, Technavio has proudly.
ReShape Lifesciences Inc. (NASDAQ:RSLS) Q2 2023 Earnings Call Transcript August 7, 2023 ReShape Lifesciences Inc. beats earnings expectations. Reported EPS is $-0.00108, expectations were $-1.79. Operator: Good afternoon, and thank you for joining the ReShape Lifesciences Second Quarter 2023 Conference Call. I would like to turn the call over to Michael Miller from Rx Communications. […]
ReShape Lifesciences® to Present Data on its Proprietary Diabetes Bloc-Stim Neuromodulation™ Device at the Keystone Symposia on Type 2 Diabetes streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
SAN CLEMENTE, Calif., Nov. 02, 2022 (GLOBE NEWSWIRE) ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health.
SAN CLEMENTE, Calif., Aug. 23, 2022 (GLOBE NEWSWIRE) ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health.